Mining the plasma proteome for cancer biomarkers
- PMID: 18385731
- DOI: 10.1038/nature06916
Mining the plasma proteome for cancer biomarkers
Abstract
Systematic searches for plasma proteins that are biological indicators, or biomarkers, for cancer are underway. The difficulties caused by the complexity of biological-fluid proteomes and tissue proteomes (which contribute proteins to plasma) and by the extensive heterogeneity among diseases, subjects and levels of sample procurement are gradually being overcome. This is being achieved through rigorous experimental design and in-depth quantitative studies. The expected outcome is the development of panels of biomarkers that will allow early detection of cancer and prediction of the probable response to therapy. Achieving these objectives requires high-quality specimens with well-matched controls, reagent resources, and an efficient process to confirm discoveries through independent validation studies.
Similar articles
-
Human body-fluid proteome: quantitative profiling and computational prediction.Brief Bioinform. 2021 Jan 18;22(1):315-333. doi: 10.1093/bib/bbz160. Brief Bioinform. 2021. PMID: 32020158 Free PMC article. Review.
-
Optomechanical devices for deep plasma cancer proteomics.Semin Cancer Biol. 2018 Oct;52(Pt 1):26-38. doi: 10.1016/j.semcancer.2017.08.011. Epub 2017 Sep 1. Semin Cancer Biol. 2018. PMID: 28867489 Review.
-
Proteomic profiling of human plasma for cancer biomarker discovery.Proteomics. 2017 Mar;17(6). doi: 10.1002/pmic.201600240. Epub 2016 Oct 17. Proteomics. 2017. PMID: 27550791 Review.
-
[Clinical proteomics and new biomarkers in biological fluids].Med Clin (Barc). 2008 Oct 4;131(11):426-34. doi: 10.1157/13126219. Med Clin (Barc). 2008. PMID: 18928725 Review. Spanish.
-
A mouse to human search for plasma proteome changes associated with pancreatic tumor development.PLoS Med. 2008 Jun 10;5(6):e123. doi: 10.1371/journal.pmed.0050123. PLoS Med. 2008. PMID: 18547137 Free PMC article.
Cited by
-
In-Depth Endogenous Phosphopeptidomics of Serum with Zirconium(IV)-Grafted Mesoporous Silica Enrichment.Anal Chem. 2024 May 28;96(21):8254-8262. doi: 10.1021/acs.analchem.3c02150. Epub 2024 May 10. Anal Chem. 2024. PMID: 38728223 Free PMC article.
-
Development and performance of NLISA for C-reactive protein detection based on Prussian blue nanoparticle conjugates.Anal Bioanal Chem. 2024 May;416(13):3097-3106. doi: 10.1007/s00216-024-05268-y. Epub 2024 Apr 18. Anal Bioanal Chem. 2024. PMID: 38635074
-
N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer.World J Gastrointest Oncol. 2024 Mar 15;16(3):659-669. doi: 10.4251/wjgo.v16.i3.659. World J Gastrointest Oncol. 2024. PMID: 38577461 Free PMC article.
-
Decoding the glycoproteome: a new frontier for biomarker discovery in cancer.J Hematol Oncol. 2024 Mar 22;17(1):12. doi: 10.1186/s13045-024-01532-x. J Hematol Oncol. 2024. PMID: 38515194 Free PMC article. Review.
-
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy.Front Immunol. 2024 Feb 29;15:1364473. doi: 10.3389/fimmu.2024.1364473. eCollection 2024. Front Immunol. 2024. PMID: 38487531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources